Malignant melanoma in a patient with Crohn's disease and treated with anti-TNF alpha

Autor: Alfonso Alcalde Vargas, Claudio Trigo Salado, Eduardo Leo Carnerero, Ana Isabel Lorente Lavirgen

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 10, Pp 639-640 (2013)

Externí odkaz: https://doaj.org/article/7367df0bb47846009b640b37b2cd81fc

Treatment with adalimumab in a patient with regenerative nodular hyperplasia secondary to azathioprine

Autor: Rafael León-Montañes, Claudio Trigo-Salado, Eduardo Leo-Carnerero, María Dolores de-la-Cruz-Ramírez, José Manuel Herrera-Justiniano, José Luis Márquez-Galán

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 3, Pp 168-170 (2013)

Introduction: regenerative nodular hyperplasia (RNH) is a rare liver disease with an etiology that is not well understood. Among the etiological factors are purine-analogue drugs such as azathioprine. Case report: we present a case of a 47-year-old p

Externí odkaz: https://doaj.org/article/73f5a8a234ef462690fa913c2f06573f

Megacolon in inflammatory bowel disease: response to infliximab

Autor: Eduardo Leo Carnerero, José Manuel Herrera Justiniano, María Dolores de la Cruz Ramírez, Andrea Núñez Ortiz, José Luis Márquez Galán, Claudio Trigo Salado

Publikováno v: Revista Española de Enfermedades Digestivas. 112

Megacolon is a serious complication of inflammatory bowel disease that often requires a colectomy. Infliximab is a therapeutic alternative when conventional treatment fails, before resorting to surgery. Its use is currently based on the publication o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fe45b7e0f2b69fc5efadbaba82541b
https://doi.org/10.17235/reed.2020.6394/2019

Topical mesalazine as a cause of Stevens-Johnson syndrome

Autor: Andrea, Núñez Ortiz, Claudio, Trigo Salado, María Dolores, de la Cruz Ramírez, José Manuel, Herrera Justiniano, Eduardo, Leo Carnerero

Publikováno v: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 110(11)

Mesalazine is a drug routinely used in ulcerative colitis and usually has few side effects. There have been reports of uncommon cases of severe mucocutaneous damage, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), induced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f742413021e9fe73b841c85505017ba2
https://pubmed.ncbi.nlm.nih.gov/29931986

Crohn's disease and cystic fibrosis: there is still a lot to learn

Autor: María Dolores de la Cruz Ramírez, Eduardo Leo Carnerero, Claudio Trigo Salado

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 12, Pp 835-836 (2018)
Revista Española de Enfermedades Digestivas v.110 n.12 2018
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Española de Enfermedades Digestivas, Volume: 110, Issue: 12, Pages: 835-836, Published: DEC 2018

The relationship between cystic fibrosis (CF) and the risk of developing inflammatory bowel disease (IBD) is not clear. CFTR mutations can influence dysbiosis and increased intestinal permeability, which are two key elements in the pathophysiology of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822b075e79fadc1bf60be87b052f12f9
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018001200018&tlng=en